Add like
Add dislike
Add to saved papers

Using within-person change in three large panel studies to estimate personality age trajectories.

How does personality change when people get older? Numerous studies have investigated this question, overall supporting the idea of so-called personality maturation. However, heterogeneous findings have left open questions, such as whether maturation continues in old age and how large the effects are. We suggest that the heterogeneity is partly rooted in methodological issues. First, studies may have failed to recover age effects as they did not stringently separate within-person changes from confounding between-person differences. Second, items supposedly belonging to the same trait may show different individual trajectories, thus rendering results sensitive to the specific set of items used. We analyzed panel data from Australia ( N = 15,268; Study 1), Germany ( N = 22,833; Study 2), and the Netherlands ( N = 10,163; Study 3) to investigate age trends in the Big Five on the levels of both scores and items. We applied a fixed effects approach that incorporates only within-person changes over time. Developmental trends in the Big Five scores were generally moderate to large and broadly confirmed personality maturation at younger ages. At older ages, maturation consistently continued for Neuroticism, whereas we found mixed evidence for such changes in Conscientiousness and Agreeableness. Furthermore, in each study, individual items showed age trends that diverged from the rest of the corresponding trait, and these differential patterns could be partly replicated across the three studies. Our results highlight the importance of items in the study of personality development and provide an explanation for previously unaccounted for variability in age trends. (PsycInfo Database Record (c) 2023 APA, all rights reserved).

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app